Close Menu

NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Thursday that its fourth quarter revenue was flat year over year.

For the three months ended Dec. 31, the company reported revenues of $990,912, down from $1.0 million in Q4 2016.

Product sales fell 23 percent to $626,498 from $818,488 a year ago. Lab services revenues fell 98 percent to $935 from $46,774, and collaboration revenues rose 157 percent to $363,479 from $141,301 year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.